Valhi Valuation
Is VHI undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
2/6Valuation Score 2/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of VHI when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: VHI ($26.06) is trading above our estimate of fair value ($0.61)
Significantly Below Fair Value: VHI is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for VHI?
Key metric: As VHI is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.
| What is VHI's PE Ratio? | |
|---|---|
| PE Ratio | 8.4x |
| Earnings | US$87.90m |
| Market Cap | US$682.75m |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 0.6x |
| Enterprise Value/EBITDA | 7x |
| PEG Ratio | n/a |
Price to Earnings Ratio vs Peers
How does VHI's PE Ratio compare to its peers?
| Company | Forward PE | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 27x | ||
ECVT Ecovyst | 17.5x | 37.3% | US$950.7m |
SCL Stepan | 36.9x | 52.5% | US$1.7b |
CCF Chase | 36.6x | n/a | US$1.2b |
MTX Minerals Technologies | 16.7x | 23.1% | US$2.6b |
VHI Valhi | 8.4x | n/a | US$682.8m |
Price-To-Earnings vs Peers: VHI is good value based on its Price-To-Earnings Ratio (8.4x) compared to the peer average (23.7x).
Price to Earnings Ratio vs Industry
How does VHI's PE Ratio compare vs other companies in the US Chemicals Industry?
Price-To-Earnings vs Industry: VHI is good value based on its Price-To-Earnings Ratio (8.4x) compared to the US Chemicals industry average (23.6x).
Price to Earnings Ratio vs Fair Ratio
What is VHI's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PE Ratio | 8.4x |
| Fair PE Ratio | n/a |
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate VHI's Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.
Discover undervalued companies
Trinseo
US$122.5m
Operates as a specialty material solutions provider in the United States, Europe, the Asia-Pacific, and internationally.
TSE
US$3.40
7D
-7.9%
1Y
-50.1%
Huntsman
US$3.4b
Manufactures and sells diversified organic chemical products worldwide.
HUN
US$19.47
7D
-2.6%
1Y
-21.8%
CMOC Group
HK$162.2b
Engages in the mining, beneficiation, smelting, and refining of base and rare metals.
CMCL.F
HK$0.81
7D
-8.0%
1Y
41.7%